Ceva Has THREE MAJOR INITIATIVES SUPPORTING OUR COMMITMENT TO POULTRY 

 

ultifend-sb-1-feature.jpg

UlTIfend IBD ND + SB-1  

The introduction of Ultifend’s IBD ND + SB-1 next generation vector vaccine. This single vaccination helps to protect against Marek’s, (HVT), Infectious Bursal Disease (IBD), Newcastle Disease (ND).

LEARN MORE 

CEVA VERONA Custom Vaccines Plant.jpg

VERONA, WI - Custom vaccines plant coming

Ceva has acquired a new production plant in Verona, WI. The plant will be dedicated to custom vaccine production. and will increase custom vaccine production capacity significantly. The plant is planned to be operational by 2Q of 2022. 

 
CEVA Guelph Immucox Plant.jpg

Guelph Canada Immucox Plant  coming 2023

Construction has started on a new facility to expand our coccidiosis vaccine manufacturing capacity. The new plant will have ten times the current manufacturing capacity. All manufacturing steps, from bird facilities, harvesting, cleaning, batching, filling, labeling, and distribution, will be under a single roof.

At Ceva, we are dedicated to helping poultry producers respond to new and emerging disease challenges, to improving bird health, and to reduce the usage of antibiotics through disease prevention. 

Bureau Veritas 

In 2022, the number of hatcheries audited under the C.H.I.C.K. Program has been expanded.

CEVA-VSE_BVCertification.jpg